虚拟现实末端运动学解释卒中上肢损伤与活动能力
结果显示平均速度与速度峰值数共同解释FMA-UE评分11%和9%的独特方差、合计16%,运动时间与速度峰值数分别解释ARAT评分13%和10%的方差。作者结论为运动学变量仅解释临床量表所捕获方差的一部分,强调卒中后上肢评估需结合运动学分析与临床量表进行多层次评定。
要点
- 平均速度与速度峰值数共同解释FMA-UE评分16%的方差。
- 运动时间与速度峰值数分别解释ARAT评分13%和10%的方差。
- 运动学变量仅解释临床量表方差的一部分,需多层次评估。
核心结论
- 运动时间、速度和平滑度等运动学变量仅解释临床观察量表所捕获方差的一部分。
- 卒中后上肢评估应同时使用运动学分析与临床量表进行多层次评定。
研究设计与样本
- 患者在虚拟环境中使用触觉笔执行目标间指向任务,同步采集末端运动学参数。
- 采用多元线性回归分析运动学变量在控制混杂变量后对FMA-UE和ARAT评分的解释方差。
主要发现
- 平均速度与速度峰值数分别独特解释FMA-UE评分11%和9%的方差,二者合计解释16%。
- 运动时间与速度峰值数分别解释ARAT评分13%和10%的方差。
关键数值与推荐
- FMA-UE与ARAT被推荐纳入卒中试验以评估上肢损伤和活动能力。
- 为理解运动恢复机制并区分恢复与代偿,推荐采用运动学分析评估卒中后上肢功能。
临床怎么用
- 卒中后上肢功能评估不应仅依赖FMA-UE和ARAT等临床量表,应结合末端运动学分析。
- 目标间指向任务采集的平均速度、速度峰值数和运动时间可作为临床量表之外的补充评估指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For evaluation of upper limb impairment and activity capacity, Fugl-Meyer Assessment of Upper Extremity (FMA-UE) and Action Research Arm Test (ARAT) are recommended to be included in stroke trials. To improve the understanding of mechanisms of motor recovery, and differentiate between restitution and compensation, kinematic analysis is also recommended for assessment of upper limb function after stroke. AIM: To determine the extent to which end-point kinematic variables obtained from the target-to-target pointing task were associated with upper limb impairment or activity limitation as assessed by traditional clinical scales in individuals with stroke. METHODS: Sixty-four individuals, from acute stage up to one year after stroke, were included from the Stroke Arm Longitudinal study at the University of Gothenburg (SALGOT) cohort. They performed a target-to-target pointing task in a virtual environment using a haptic stylus which also captured the kinematic parameters. Multiple linear regression was done to determine the amount of variance explained by kinematic variables on FMA-UE and ARAT scores after controlling for confounding variables. RESULTS: Mean velocity and number of velocity peaks explained 11 and 9% of the FMA-UE score uniquely and 16% when taken together. Movement time and number of velocity peaks explained 13 and 10% of the ARAT score respectively. CONCLUSION: The kinematic variables of movement time, velocity and smoothness explain only a part of the variance captured by using clinical observational scales, reinforcing the importance of multi-level assessment using both kinematic analysis and clinical scales in upper limb evaluation after stroke. TRIAL REGISTRATION: The trial was registered with register number NCT01115348 at clinicaltrials.gov , on May 4, 2010. URL: https://clinicaltrials.gov/ct2/show/NCT01115348 .
引用
- Hussain N, Sunnerhagen KS, Alt Murphy M, et al. End-point kinematics using virtual reality explaining upper limb impairment and activity capacity in stroke. J Neuroeng Rehabil. 2019. PMID: 31262320. doi:10.1186/s12984-019-0551-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。